NCT01065389

Brief Summary

Dialysis patients usually have peripheral muscle weakness due to metabolic disturbances (increased protein catabolism) and fatigue. This muscle weakness may decrease functional capacity and quality of life. It also serves to increase cardiovascular risk factors in these end stage renal disease patients. Peripheral muscle strength training shall combat physical inactivity during dialysis. In the investigators trial, the investigators hypothesis that peripheral muscle training might regulate protein catabolic rate,renal functions, cardiovascular risk factors, improve functional capacity and quality of life in endstage renal disease patients undergoing dialysis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Oct 2010

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 4, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 9, 2010

Completed
8 months until next milestone

Study Start

First participant enrolled

October 1, 2010

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

September 10, 2013

Status Verified

September 1, 2013

Enrollment Period

4.5 years

First QC Date

February 4, 2010

Last Update Submit

September 8, 2013

Conditions

Keywords

IntradialysisResistance trainingProtein Catabolic RateUrea kineticsQuality of lifeVO2 max

Outcome Measures

Primary Outcomes (1)

  • Serum and Urea biochemistry - electrolytes (Na, K+), serum albumin, inflammatory markers, urea kinetics, protein catabolic rate

    Bimonthly

Secondary Outcomes (7)

  • Maximal Oxygen Consumption (VO2 max) and Heart Rate Recovery through Queens College step test

    Once Monthly

  • Fat levels by skin fold measurements

    Once monthly

  • Handgrip strength by dynamometer

    Once monthly

  • Six minute walk test distance

    Once monthly

  • Quality of life (KDQOL - SF questionnaire)

    Once monthly

  • +2 more secondary outcomes

Study Arms (2)

Prgressive Resistance Exercise Training

EXPERIMENTAL

Progressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks

Behavioral: Progressive Resistance Exercise Training

Unstructured Resistance Exercise

ACTIVE COMPARATOR

Unstructured Resistance Exercise thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.

Behavioral: Unstructured Nonprogressive resistance exercise

Interventions

Progressive Resistance Exercise Training thrice a week for 12 weeks. For first two weeks, 60% of 5 repetition maximum, progressing at 5% of 5 repetition maximum each week reaching upto 110% of 5 Repetition maximum at the end of 12 weeks

Also known as: Strength Training
Prgressive Resistance Exercise Training

Unstructured Resistance Exercise 30 minutes a day, thrice a week for 12 weeks. For 12 weeks, 20% 5 repetition maximum (which will not induce training effect and any physiological responses)and free range of motion exercises with no progression.

Also known as: Non progressive strength training
Unstructured Resistance Exercise

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Must have end stage renal disease (diagnosed and the stage graded by nephrologist or the intensivist concerned) for more than 6 months and dialysis for at least 3 months (the impact of exercise training can be easily assessed)
  • Must be between the ages of 30 - 60 years of age/ both genders.
  • Must be able to understand the purpose of exercise testing and resistance training.

You may not qualify if:

  • Those with acute nephritic syndrome and hematuria \< 2 months.
  • Those with profound anemia and blood transfusion \< 2 months
  • Those underwent renal transplantation \< 6 months.
  • Those receiving/ received cytotoxic drugs - amiloride, azathioprine/ aspirin (antiplatelets)\< 2 months
  • Those with coagulation disorders or under anticoagulants \< 4 months.
  • Those underwent recent cardiac surgeries and with recent unstable cardiac failures
  • Those with recent cerebrovascular accidents \< 6 months
  • Those have recent urinary tract infections, Renal and bladder carcinomas \< 2 months
  • Those with absolute contraindications for resistance exercise training (as per American College of Sports Medicine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central Referral Hospital, SMIMS

Gangtok, Sikkim, 737102, India

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Baskaran Chandrasekaran, MPT

    Lecturer / Consultant cardiopulmonary Physiotherapist

    PRINCIPAL INVESTIGATOR
  • Bidhan C Sharma, MPT

    Assistant Professor/ Consultant Physiotherapist

    STUDY CHAIR
  • Manish Goon, BPT

    Clinical Physiotherapist

    STUDY CHAIR
  • Nikita Joshi, MPT

    Head of Department/ Associate Professor

    STUDY CHAIR
  • Arpan Battacharia, MD

    Dialysis Unit Incharge

    STUDY CHAIR
  • Bidita Kandelwal, MD

    Head of Medicine Department

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Physiotherapist

Study Record Dates

First Submitted

February 4, 2010

First Posted

February 9, 2010

Study Start

October 1, 2010

Primary Completion

April 1, 2015

Study Completion

August 1, 2016

Last Updated

September 10, 2013

Record last verified: 2013-09

Locations